VU319 Shows Safe Profile and Potential as M1 Allosteric Modulator for MCI

Guest User

by: Marco Meglio
NeurologyLive

Appello Pharma completes Series A to advance treatment of Parkinson's

Committed to Memory: VU319 may hold the key to improving memory loss in Alzheimer's patients